ACADIA Pharmaceuticals Inc. vs Genuine Parts Company — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Genuine Parts Company trades at $135.22 (market cap $18.62B). The key difference: Genuine Parts Company is far larger — about 3.7× ACADIA Pharmaceuticals Inc.'s market cap, and Genuine Parts Company pays a 3.15% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | GPC | |
|---|---|---|
Market Cap | $5.07B | $18.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $149.26 |
52-Week Low | $20.06 | $92.47 |
Enterprise Value | $4.19B | $24.72B |
Dividend Yield | — | 3.15% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →